• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Ciox Health Acquires Biomedical NLP Company Medal

by Jasmine Pennic 07/28/2020 Leave a Comment

Ciox Health Acquires Biomedical NLP Company Medal

What You Should Know:

– Ciox Health has acquired Medal, Inc., a biomedical Natural Language Processing (biomed-NLP) technology company.

– The acquisition will lead Ciox to better and more quickly enable real-world data in support of research that advances patient care.


Ciox Health, a leading health technology company, today announced its acquisition of San Francisco-based biomedical Natural Language Processing (biomed-NLP) technology company, Medal, Inc., a leader in the application of AI techniques to the interrogation of unstructured medical record data. The acquisition accelerates capabilities to enable real-world data (RWD) in support of research that advances patient care.

The Real-World Data Advantage

As more pharmaceutical and research organizations look to real-world data to accelerate clinical research, reliable identification, and interpretation of phenotypic data from deep inside medical records are becoming paramount. The most relevant information resides in the unstructured data: the surgical reports, pathology reports, imaging reports, discharge summaries, and other clinician-scribed narrative text. Medal’s software helps identify, contextualize, and interpret narrative-based medical notes, leading to the creation of research-grade data sets at scale. The company’s approach to biomed-NLP and deep learning AI is guided and informed by consensus from clinical expert reviewers across therapeutic areas.

“More than 100 million medical records are retrieved and reviewed by Ciox each year from the vast majority of U.S. providers, presenting an unprecedented opportunity to actually bring a true longitudinal perspective to clinical investigation. Ciox works at the first and last mile of U.S. healthcare data,” says Andy McMurry, Ph.D., Chief Science Officer of Medal. “Using Medal AI, Ciox will reduce human expert time and increase the utility of patient data to support biomedical discovery and clinical trials research across many disease areas, including COVID-19. Combining vast biomedical knowledge sources with clinically trained Artificial Intelligence enabling human experts, we are reinventing real-world data for clinical investigation.”

Acquisition Benefits for Ciox Health

This acquisition is the third major recent announcement from Ciox’s growing Real World Data business, following two prior announcements of strategic collaborations with LabCorp and Merck. As health data remains fragmented throughout the U.S. healthcare ecosystem, Ciox is attracting interest in its RWD division from medical research organizations and other partners. This additional feature of the Ciox DataFit Platform through the acquisition of Medal will enable faster and more consistent translational research. 

Why It Matters

“We’re proud to bolster the Ciox Real World Data offering with Medal’s technology and team,” says Pete McCabe, CEO, Ciox. “The team and the biomed-NLP product, combined with Ciox’s technology-enabled ability to create longitudinal records across EHRs and provider systems, remove the friction related to medical records-based clinical research.  We will consistently supply consented, HIPAA-compliant, de-identified, research-grade RWD for complex clinical use cases to commercial researchers in pharma and biotech, as well as government sponsored researchers. The need is particularly highlighted in the COVID-19 research questions being asked by agencies like the FDA, CDC and NIH.”

RELATED:   Carrot Enters Global Market for Tobacco Cessation with it’s CE Marked Breath Sensor

Tagged With: AI, Artificial Intelligence, Biomedical Knowledge, Biotech, CIOX, Ciox Health, clinical research, Clinical Trials, Deep Learning, FDA, Healthcare Data, Healthcare Mergers & Acquisitions, Healthcare Natural Language Processing, HIPAA, hipaa-compliant, LabCorp, medical records, Natural Language Processing (NLP), NIH, NLP, Partners, Patient Care, Pharma, SAN FRANCISCO, unstructured data

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Open APIs in Healthcare: The Future of Data Integration Report
How COVID-19 is Driving Changes in Hospital Safety Through Technology »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • CVS Health Launches Senior Medical Alert System, Symphony

    CVS Health Launches Senior Medical Alert System, Symphony

    ... more
  • Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health

    Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A

    ... more
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup

    MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process

    ... more
  • Heritage Group

    Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund

    ... more

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021 Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021
  • Heritage Group Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • How-COVID-19-Reshaped-Healthcare-Consumerism-4-Key-Trends-to-Know-for-2021 How COVID-19 Reshaped Healthcare Consumerism & 4 Key Trends to Know for 2021
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch
  • Healthcare Breach Report 2016 6 Ways Health Informatics Is Transforming Health Care

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |